Literature DB >> 6071878

Hypercalcemia. Experience with phosphate and sulfate therapy.

M Kahil, B Orman, F Gyorkey, H Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6071878     DOI: 10.1001/jama.201.10.721

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  On the genesis of the clinical manifestations of hypercalcemic disorders.

Authors:  S G Massry; D A Goldstein
Journal:  West J Med       Date:  1978-10

2.  Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.

Authors:  K Suzuki; K Nonaka; N Kono; K Ichihara; Y Fukumoto; Y Inui; J Miyagawa; T Onishi; C Hayashi; S Tarui
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

3.  Control of hypercalcemia with mithramycin.

Authors:  E G Ellas; G Reynoso; A Mittelman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

4.  Hypercalcemic crisis and intractable gastrointestinal ulceration in a patient with endocrine polyglandular syndrome.

Authors:  R E Condon; G E Granville; P H Jordan; A H Helgason
Journal:  Ann Surg       Date:  1968-02       Impact factor: 12.969

5.  A case of acute hyperparathyroidism, with thyrotoxicosis and pancreatitis, presenting as hyperemesis gravidarum.

Authors:  M A Soyannwo; M Bell; M G McGeown; T G Milliken
Journal:  Postgrad Med J       Date:  1968-11       Impact factor: 2.401

6.  [Phosphate treatment in hypercalcemia].

Authors:  H J Kistler; W Neubauer
Journal:  Klin Wochenschr       Date:  1970-06-15

Review 7.  [Hypo and hypercalcemia as an emergency].

Authors:  H G Haas; M A Dambacher; J Guncaga
Journal:  Klin Wochenschr       Date:  1975-05-15

8.  Phosphate treatment of hypercalcaemia due to carcinoma.

Authors:  N Thalassinos; G F Joplin
Journal:  Br Med J       Date:  1968-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.